Editor-in-Chief, Robert Amdur, MD, discusses an article from the September/October issue of PRO, “Sparing the Larynx and Hypopharynx with Radiotherapy for Squamous Cell Carcinoma of Unknown Primary Site and Predominant Adenopathy in Level IIA” and gives his five principles for deciding which mucosal sites to treat with an unknown primary.